Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vision blurred
Clinical narrative: severe headaches; fatigue; tinnitus; joint pain; face tics; left sided sensation loss; blurry vision; demyelinating process in brain; optic atrophy; acquired hashimoto's after third vaccine; hemiparesis; muscle weakness; ataxia; dysarthria; expressive aphasia; tremors; This is a spontaneous report received from a Consumer or other non HCP.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 31Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 37 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Preexisting Leukodystrophy, migraine headaches with auras and iron deficiency anemia" (unspecified if ongoing); "migraine headaches with auras" (unspecified if ongoing), notes: Migraine headaches with auras; "iron deficiency anemia" (unspecified if ongoing). Concomitant medication(s) included: FLU VACCINE VII taken for immunisation, on 11Nov2021 as dose 1, single; DESVENLAFAXINE. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Unknown. Misplaced/discarded, Location of injection: Arm Right), administration date: 26Jul2021, when the patient was 37-year-old; BNT162b2 (Dose Number: 2, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Right), administration date: 08Aug2021, when the patient was 37-year-old. The following information was reported: AUTOIMMUNE THYROIDITIS (hospitalization, disability, medically significant) with onset 10Feb2022, outcome "not recovered", described as "acquired hashimoto's after third vaccine"; ATAXIA (hospitalization, disability) with onset 10Feb2022, outcome "not recovered"; DEMYELINATING POLYNEUROPATHY (hospitalization, disability, medically significant) with onset 10Feb2022, outcome "not recovered", described as "demyelinating process in brain"; DYSARTHRIA (hospitalization, disability) with onset 10Feb2022, outcome "not recovered"; APHASIA (hospitalization, disability) with onset 10Feb2022, outcome "not recovered", described as "expressive aphasia"; HEMIPARESIS (hospitalization, disability, medically significant) with onset 10Feb2022, outcome "not recovered"; MUSCULAR WEAKNESS (hospitalization, disability) with onset 10Feb2022, outcome "not recovered", described as "muscle weakness"; OPTIC ATROPHY (hospitalization, disability, medically significant) with onset 10Feb2022, outcome "not recovered"; TREMOR (hospitalization, disability) with onset 10Feb2022, outcome "not recovered", described as "tremors"; HEADACHE (hospitalization, disability), outcome "not recovered", described as "severe headaches"; FATIGUE (hospitalization, disability), outcome "not recovered"; TINNITUS (hospitalization, disability), outcome "not recovered"; ARTHRALGIA (hospitalization, disability), outcome "not recovered", described as "joint pain"; TIC (hospitalization, disability), outcome "not recovered", described as "face tics"; SENSORY LOSS (hospitalization, disability), outcome "not recovered", described as "left sided sensation loss"; VISION BLURRED (hospitalization, disability), outcome "not recovered", described as "blurry vision". The patient was hospitalized for demyelinating polyneuropathy, optic atrophy, autoimmune thyroiditis, hemiparesis, muscular weakness, ataxia, dysarthria, aphasia, tremor, headache, fatigue, tinnitus, arthralgia, tic, sensory loss, vision blurred (hospitalization duration: 1 day(s)). The events "demyelinating process in brain", "optic atrophy", "acquired hashimoto's after third vaccine", "hemiparesis", "muscle weakness", "ataxia", "dysarthria", "expressive aphasia", "tremors", "severe headaches", "fatigue", "tinnitus", "joint pain", "face tics" and "blurry vision" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Jan2022) Positive. Therapeutic measures were not taken as a result of demyelinating polyneuropathy, optic atrophy, autoimmune thyroiditis, hemiparesis, muscular weakness, ataxia, dysarthria, aphasia, tremor, headache, fatigue, tinnitus, arthralgia, tic, sensory loss, vision blurred.  Clinical course: Patient was not tested for Covid prior to vaccination and was tested for Covid post vaccination